Samson SL, Nachtigall LB, Fleseriu M et al (2020) Maintenance of acromegaly control in patients switching from injectable somatostatin receptor ligands to oral octreotide. J Clin Endocrinol Metab 105:e3785–e3797. https://doi.org/10.1210/clinem/dgaa526

Article  PubMed  PubMed Central  Google Scholar 

Melmed S, Popovic V, Bidlingmaier M et al (2015) Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial. J Clin Endocrinol Metab 100:1699–1708. https://doi.org/10.1210/jc.2014-4113

Article  CAS  PubMed  Google Scholar 

Madan A, Zhu YF, Markison S et al (2019) Final results from the first in man phase 1 clinical trial of CRN00808, an orally bioavailable sst2-selective, nonpeptide somatostatin biased agonist, for the treatment of acromegaly: safety, pharmacokinetics, pharmacodynamics, and midazolam drug interaction in healthy volunteers. J Endocr Soc 3(Suppl-1):SAT–249

Basu R, Nahar K, Kulkarni P et al (2021) A novel peptide antagonist of the human growth hormone receptor. J Biol Chem 296:100588. https://doi.org/10.1016/j.jbc.2021.100588

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brito JP, Ross JS, El Kawkgi OM, Maraka S, Deng Y, Shah ND, Lipska KJ (2021) Levothyroxine use in the United States, 2008–2018. JAMA Intern Med 181:1402–1405. https://doi.org/10.1001/jamainternmed.2021.2686

Article  CAS  PubMed  PubMed Central  Google Scholar 

la Cour JL, Medici BR, Grand MK, Nicolaisdottir DR, Lind B, Faber J, Andersen CL, Nygaard B (2021) Risk of over- and under- treatment with levothyroxine in primary care in Copenhagen, Denmark. Eur J Endocrinol 185:673–679. https://doi.org/10.1530/EJE-21-0485

Article  PubMed  Google Scholar 

Stott DJ, Rodondi N, Kearney PM et al; TRUST Study Group (2017) Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med 376:2534–2544. https://doi.org/10.1056/NEJMoa1603825

Peeters RP (2017) Subclinical hypothyroidism. N Engl J Med 376:2556–2565. https://doi.org/10.1056/NEJMcp1611144

Article  PubMed  Google Scholar 

Korevaar TIM, Medici M, Visser TJ, Peeters RP (2017) Thyroid disease in pregnancy: new insights in diagnosis and clinical management. Nat Rev Endocrinol 13:610–622. https://doi.org/10.1038/nrendo.2017.93

Article  CAS  PubMed  Google Scholar 

Yim Y, Na DG, Ha EJ et al (2020) Concordance of three international guidelines for thyroid nodules classified by ultrasonography and diagnostic performance of biopsy criteria. Korean J Radiol 21:108–116. https://doi.org/10.3348/kjr.2019.0215

Article  PubMed  Google Scholar 

Ramonell KM, Ohori NP, Liu JB et al (2023) Changes in thyroid nodule cytology rates after institutional implementation of the thyroid imaging reporting and data system. Surgery 173:232–238. https://doi.org/10.1016/j.surg.2022.06.061

Article  PubMed  Google Scholar 

Cancer Genome Atlas Research N (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159:676–90. https://doi.org/10.1016/j.cell.2014.09.050

Article  CAS  Google Scholar 

Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA (2023) The 2023 Bethesda system for reporting thyroid cytopathology. Thyroid 33:1039–1044. https://doi.org/10.1089/thy.2023.0141

Article  PubMed  Google Scholar 

Hu TX, Nguyen DT, Patel M et al (2022) The effect modification of ultrasound risk classification on molecular testing in predicting the risk of malignancy in cytologically indeterminate thyroid nodules. Thyroid 32:905–916. https://doi.org/10.1089/thy.2021.0659

Article  CAS  PubMed  Google Scholar 

In H, Neville BA, Lipsitz SR et al (2012) The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidence. Ann Surg 255:890–5. https://doi.org/10.1097/SLA.0b013e31824deae6

Article  PubMed  Google Scholar 

Elwyn G, Edwards A, Britten N (2003) What information do patients need about medicines? “Doing prescribing”: how doctors can be more effective. BMJ. 327:864–7. https://doi.org/10.1136/bmj.327.7419.864

Article  PubMed  PubMed Central  Google Scholar 

Wallner L, Reyes-Gastelum D, Hamilton AS, Ward KC, Wawley ST, Haymart MR (2019) JCO 37:2152–2161. https://doi.org/10.1200/JCO.18.02228

Article  Google Scholar 

Chou R, Dana T, Brent GA et al (2022) Serum thyroglobulin measurement following surgery without radioactive iodine for differentiated thyroid cancer: a systematic review. Thyroid 32:613–39. https://doi.org/10.1089/thy.2021.0666

Article  CAS  PubMed  Google Scholar 

Papaleontiou M, Zebrack B, Reyes-Gastelum D et al (2021) Physician management of thyroid cancer patients’ worry. J Cancer Surviv 15:418–426. https://doi.org/10.1007/s11764-020-00937-0

Article  PubMed  Google Scholar 

Haymart P, Levin NJ, Haymart MY (2023) The psychosocial impact of thyroid cancer. Curr Opin Endocrinol Diabetes Obes 30:252–258. https://doi.org/10.1097/MED.0000000000000815

Article  PubMed  Google Scholar 

Bouillon R, Bikle D (2019) Vitamin D metabolism revised: fall of dogmas. J Bone Miner Res. 34:1985–1992. https://doi.org/10.1002/jbmr.3884

Article  PubMed  Google Scholar 

Chakhtoura M, Bacha D, Gharios C et al (2022) Vitamin D supplementation and fractures in adults: a systematic umbrella review of meta-analyses of controlled trials. J Clin Endocrinol Metab 107:882–898. https://doi.org/10.1210/clinem/dgab742

Article  PubMed  Google Scholar 

Cappola AR, Auchus RJ, El-Hajj Fuleihan G et al (2023) Hormones and ageing: an endocrine society scientific position statement. J Clin Endocrinol Metabol 108:1835–1874. https://doi.org/10.1210/clinem/dgad225

Article  Google Scholar 

Vitamin D for the prevention of disease: an endocrine society clinical practice guideline survey (http://surveymonkey.com)

Bouillon R, LeBoff M, Neale RE (2023) Health effects of vitamin D supplementation: lessons learned from randomized controlled trials and mendelian randomization studies. J Bone Miner Res 38:1391–1403. https://doi.org/10.1002/jbmr.4888

Article  PubMed  Google Scholar 

Cerdá Gabaroi D, Peris P, Monegal A et al (2010) Search for hidden secondary causes in postmenopausal women with osteoporosis. Menopause 17:135–9. https://doi.org/10.1097/gme.0b013e3181ade8e5

Article  PubMed  Google Scholar 

Bours SP, van den Bergh JP, van Geel TA, Geusens PP (2014) Secondary osteoporosis and metabolic bone disease in patients 50 years and older with osteoporosis or with a recent clinical fracture: a clinical perspective. Curr Opin Rheumatol 26:430–9. https://doi.org/10.1097/BOR.0000000000000074

Article  CAS  PubMed  Google Scholar 

Camacho PM, Petak SM, Binkley N et al (2020) American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract 26(Suppl 1):1–46. https://doi.org/10.4158/GL-2020-0524SUPPL

Article  PubMed  Google Scholar 

Parvizi J, Shohat N, Gehrke T (2017) Prevention of periprosthetic joint infection. Bone Joint J 99(Suppl B):3–10. https://doi.org/10.1302/0301-620X.99B4.BJJ-2016-1212.R1

Article  PubMed  Google Scholar 

Korytkowski MT, Muniyappa R, Antinori-Lent et al (2022) Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 107:2101–2128. https://doi.org/10.1210/clinem/dgac278

Article  PubMed  PubMed Central  Google Scholar 

Crowley K, O Scanaill P, Hermanides J, Buggy DJ (2023) Current practice in the perioperative management of patients with diabetes mellitus: a narrative review. Brit J Anaesthesia 131:242–252. https://doi.org/10.1016/j.bja.2023.02.039

Article  Google Scholar 

Kirwan JP, Courcoulas AP, Cummings DE et al (2022) Diabetes remission in the alliance of randomized trials of medicine versus metabolic surgery in type 2 diabetes (ARMMS-T2D). Diabetes Care 45:1574–1583. https://doi.org/10.2337/dc21-2441

Article  PubMed  PubMed Central  Google Scholar 

Mingrone G, Panunzi S, De Gaetano A et al (2021) Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 397:293–304. https://doi.org/10.1016/S0140-6736(20)32649-0

Article  PubMed  Google Scholar 

Sandoval DA, Patti ME (2023) Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia. Nat Rev Endocrinol 19:164–176. https://doi.org/10.1038/s41574-022-00757-5

Article  PubMed  Google Scholar 

Suhl E, Anderson-Haynes SE, Mulla C, Patti ME (2017) Medical nutrition therapy for post bariatric hypoglycemia: practical insights. Surg Obes Relat Dis 13:888–896. https://doi.org/10.1016/j.soard.2017.01.025

Article  PubMed  PubMed Central  Google Scholar 

Ohrstrom CC, Worm D, Hojager A et al (2019) Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide. Diabetes Obes Metab 21:2142–2151. https://doi.org/10.1111/dom.13796

Article  CAS  PubMed  Google Scholar 

Donini LM, Busetto L, Bischoff SC et al (2022) Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO Consensus Statement. Obes Facts 15:321–35. https://doi.org/10.1159/000521241

Article  PubMed  PubMed Central  Google Scholar 

Atkins JL, Wannamathee SG (2020) Sarcopenic obesity in ageing: cardiovascular outcomes and mortality. Br J Nutr 124:1102–13. https://doi.org/10.1017/S0007114520002172

Article  CAS